Product
Blood-based assay
1 clinical trial
1 indication
Indication
Prostate CancerClinical trial
Plasma Amyloid-beta 42/40 to Predict Cognitive Decline From Androgen Deprivation Therapy in Prostate Cancer: a Prospective Observational StudyStatus: Recruiting, Estimated PCD: 2026-05-31